Pages that link to "Q155746"
Jump to navigation
Jump to search
The following pages link to paricalcitol (Q155746):
Displayed 34 items.
- vitamin D receptor (Q417057) (← links)
- kidney failure (Q476921) (← links)
- chronic renal insufficiency (Q736715) (← links)
- kidney disease (Q1054718) (← links)
- hyperparathyroidism (Q1344835) (← links)
- secondary hyperparathyroidism (Q3622611) (← links)
- Zemplar (Q47522341) (← links)
- Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients (Q63816744) (← links)
- Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism (Q63817885) (← links)
- A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism (Q63830046) (← links)
- Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass Surgery (Q63833274) (← links)
- Reno- and Vascular Protective Effect of a Vitamin-D-analogue in Moderate to Severe Chronic Kidney Disease (Q63833747) (← links)
- Paricalcitol Effect on Anemia in CKD (Q63844635) (← links)
- Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD) (Q64042633) (← links)
- Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis (Q64048397) (← links)
- Efficacy and safety of paricalcitol in patients undergoing hemodialysis: a meta-analysis (Q64106514) (← links)
- Three Therapeutic Strategies: Cinacalcet, Paricalcitol or Both in Secondary Hyperparathyroidism Treatment in Hemodialysed Patients During 1-Year Observational Study-A Comparison (Q64236654) (← links)
- Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation. (Q64354982) (← links)
- Paricalcitol Over Inflammatory Parameters on Chronical Kidney Disease Patients (Q64625133) (← links)
- Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study) (Q64625185) (← links)
- Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Transplant Recipients (Q64647873) (← links)
- Metabolic Effects of Paricalcitol (Q64660830) (← links)
- Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D (Q64663004) (← links)
- Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease (Q64709389) (← links)
- Oral Paricalcitol in Kidney Transplant Recipients (Q64725963) (← links)
- A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer (Q64790275) (← links)
- Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes (Q65375518) (← links)
- Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice (Q65376684) (← links)
- Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism (Q65377012) (← links)
- A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD) (Q76983909) (← links)
- User:DeltaBot/fixClaims/maintenance/P715format (← links | edit)
- Wikidata:Database reports/Constraint violations/P486 (← links | edit)
- Wikidata:Database reports/Constraint violations/P2275 (← links | edit)
- Wikidata:Database reports/Constraint violations/P4235 (← links | edit)